Improvement of debilitating tardive dyskinesia with risperidone

Annals of Clinical Psychiatry

Volumn 8, Issue 1, 1996, Pages 27-29

  Rangwani, Sunil R ^a   Gupta, Sanjay ^a,b,d   Burke, William J ^a   Potter, Jane ^c  

^a Creighton Nebraska Psychiat R P   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Olean General Hospital   (United States)

Author keywords

Dyskinesia; Efficacy; Risperidone; Tardive

Indexed keywords

DIPHENHYDRAMINE; FLAVOXATE; NEUROLEPTIC AGENT; RISPERIDONE; THIORIDAZINE;

AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; PSYCHOSIS; TARDIVE DYSKINESIA;

EID: 0029954054     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.3109/10401239609149088     Document Type: Article

References (16)

1. Kane JM, Woerner M, Lieberman J: Prevalence, incidence, and risk factors. J Clin Psychopharmacol 1988; 8 (Suppl):52-56
2. Benson DF, Blumer D, eds. Psychiatric Aspects of Neurologic Disease, Vol II. New York: Grune and Stratton; 1982
3. Jeste DV, Wyatt RJ: In: Understanding and Treating Tardive Dyskinesia. New York: Guildford Press; 1982:10-38
4. Kane JM, Smith JM: Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 1982; 39:473-481
5. Chouinard G, Annable L, Ross-Chouinard A: A five year prospective longitudinal study of tardive dyskinesia. J Clin Psychopharmacol 1988; 8:S21-S26
6. Lieberman J, Lesser M, Johns C, Pollack S, Saltz B, Kane J: Pharmacologic studies of tardive dyskinesia. J Clin Psychopharmacol 1988; 8:57S-63S
7. Barnes TRE, Liddle PF, Curson DA, Patel M: Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia. Br J Psychiatry 1989; Suppl 7:99-103
8. Folstein MF, Folstein SE, McHugh P: "Mini Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
9. Hughes CP, Berg L, Danziger WL: A new clinical scale for staging dementia. Br J Psychiatry 1982; 140:566-572
10. Berg L: Mild dementia of the Alzheimer type: Diagnostic criteria and natural history. Mt Sinai J Med 1988; 55:87-96
11. Simpson GM, Lee JH, Shrivastava RK: Clozapine in tardive dyskinesia. Psychopharmacology 1978; 56:75-80
12. Small JG, Milstein V, Marhenke JD, Hall DD, Kellams JJ: Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. J Clin Psychiatry 1987; 48:263-267
13. Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J: The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991; 158:503-510
14. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ: Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992; 149:773-777
15. Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, Angrist B: Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 1993; 150:1405-1407
16. Gupta S, Black DW, Smith DA: Risperidone: Review of its pharmacology, and therapeutic use in schizophrenia. Ann Clin Psychiatry 1994; 6:173-180